Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-020152
Filing Date
2017-03-13
Accepted
2017-03-13 16:09:02
Documents
1
Period of Report
2017-03-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4056
  Complete submission text file 0001209191-17-020152.txt   5368
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Koenig Scott (Reporting) CIK: 0001587514 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36177 | Film No.: 17685336